Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 78.49M | $ 21.13M | 26.92% |
3/31/2025 | $ 73.89M | $ 19.51M | 26.4% |
12/31/2024 | $ 73.42M | $ 21.24M | 28.93% |
9/30/2024 | $ 61.56M | $ 17.2M | 27.94% |
6/30/2024 | $ 91.54M | $ 20.72M | 22.63% |
3/31/2024 | $ 89.83M | $ 22.35M | 24.88% |
12/31/2023 | $ 84.43M | $ 19.05M | 22.56% |
9/30/2023 | $ 87.57M | $ 21.58M | 24.65% |
6/30/2023 | $ 88.42M | $ 19.64M | 22.21% |
3/31/2023 | $ 66.56M | $ 20.3M | 30.5% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: Inventory [ $ 13.28M ] / Assets [ $ 72.31M ]
(=) Inv. to Assets [ 18.37% ]
Minimum
Jun 30, 2021
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.1% |